Natpara and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Natpara (parathyroid hormone), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Levemir, and have Hypoparathyroidism.

The study is created by eHealthMe based on reports of 4,485 people who have side effects when taking Natpara from the FDA, and is updated regularly.

What is Natpara?

Natpara has active ingredients of parathyroid hormone. eHealthMe is studying from 4,488 Natpara users. Check the latest studies of Natpara.

On Jul, 21, 2026

4,485 people reported to have side effects when taking Natpara.
Among them, 25 people (0.56%) died.

Among these 25 people:

How long have people been on Natpara when they died? *

What is the gender of people who died when taking Natpara? *

female: 65.22 %
male: 34.78 %

What is the age of people who died when taking Natpara? *

What are other drugs people take besides Natpara? *

What are other side effects people have before they died? *

Weakness: 2 people, 8.00%
Dehydration (dryness resulting from the removal of water): 2 people, 8.00%
Weight Decreased: 1 person, 4.00%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 4.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 4.00%
Septic Shock (shock due to blood infection): 1 person, 4.00%
Retching (strong involuntary effort to vomit): 1 person, 4.00%
Pancreatitis (inflammation of pancreas): 1 person, 4.00%
Gait Disturbance: 1 person, 4.00%
Fever: 1 person, 4.00%

What are the existing conditions these people have? *

Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 12 people, 48.00%
Post Procedural Hypothyroidism: 2 people, 8.00%
Vitamin B12 Deficiency: 1 person, 4.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 4.00%
Prostatomegaly (enlargement of the prostate): 1 person, 4.00%
Inflammatory Bowel Disease: 1 person, 4.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.00%
Hyperthyroidism (over activity of the thyroid gland): 1 person, 4.00%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 4.00%
High Blood Pressure: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Natpara:

Natpara (4,488 reports)

Expand to all the drugs that have ingredients of parathyroid hormone:

Death and drugs with ingredients of parathyroid hormone (66 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Natpara:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,126 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on parathyroid hormone (the active ingredients of Natpara) and Natpara (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.